Cardiocare Medical Systems Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 13-12-2024
- Paid Up Capital ₹ 0.90 M
as on 13-12-2024
- Company Age 9 Year, 5 Months
- Last Filing with ROC 31 Mar 2020
- Revenue %
(FY 2020)
- Profit -7.60%
(FY 2020)
- Ebitda 57.56%
(FY 2020)
- Net Worth -68.10%
(FY 2020)
- Total Assets -37.76%
(FY 2020)
About Cardiocare Medical Systems
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.90 M, as per Ministry of Corporate Affairs (MCA) records.
Ramesh Reddy and Siva Naraharisetti serve as directors at the Company.
- CIN/LLPIN
U33111AP2015PTC096894
- Company No.
096894
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Jun 2015
- Date of AGM
30 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Visakhapatnam, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cardiocare Medical Systems?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ramesh Reddy | Director | 30-Jun-2015 | Current |
Siva Naraharisetti | Director | 09-Sep-2019 | Current |
Financial Performance of Cardiocare Medical Systems.
Cardiocare Medical Systems Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 7.6% decrease in profit. The company's net worth observed a substantial decline by a decrease of 68.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Cardiocare Medical Systems?
In 2017, Cardiocare Medical Systems had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Krr Farm Products Private LimitedActive 6 years 2 months
Ramesh Reddy and Siva Naraharisetti are mutual person
- Welfare Agritech Private LimitedActive 6 years 1 month
Ramesh Reddy and Siva Naraharisetti are mutual person
- Harithandhra Farm Products Private LimitedActive 6 years 3 months
Ramesh Reddy and Siva Naraharisetti are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cardiocare Medical Systems?
Unlock and access historical data on people associated with Cardiocare Medical Systems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cardiocare Medical Systems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cardiocare Medical Systems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.